A secreted FGF-binding protein can serve as the angiogenic switch in human cancer

Nature Medicine

Volumn 3, Issue 10, 1997, Pages 1137-1140

  Czubayko, Frank ^a   Liaudet Coopman, Emmanuelle D E ^a   Aigner, Achim ^a   Tuveson, Anne T ^a   Berchem, Guy J ^a   Wellstein, Anton ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SECRETION;

ADULT; ANIMALS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE; COLONIC NEOPLASMS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OPEN READING FRAMES; RECOMBINANT FUSION PROTEINS; RNA, CATALYTIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030746972     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1097-1137     Document Type: Article

References (20)

1. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147, 9-19 (1995).
2. Liotta, L.A., Steeg, P.S. & Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64, 327-336 (1991).
3. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
4. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039 (1995).
5. Schulte, A.M. et al. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ line insertion of an endogenous retrovirus. Proc. Natl. Acad. Sci. USA 93, 14759-14764 (1996).
6. Czubayko, F., Schulte, A.M., Berchem, G.J. & Wellstein, A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl. Acad. Sci. USA 93, 14753-14758 (1996).
7. Asano, M., Yukita, A., Matsumoto, T., Kondo, S. & Suzuki, H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res. 55, 5296-5301 (1995).
8. Warren, R.S., Yuan, H., Matli, M.R., Gillett, N.A. & Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789-1797 (1995).
9. Wu, D., Kan, M., Sato, G.H., Okamoto, T. & Sato, J.D. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266, 16778-16785 (1991).
10. Czubayko, F., Smith, R.V., Chung, H.C. & Wellstein, A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem. 269, 28243-28248 (1994).
11. Burgess, W.H. & Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606 (1989).
12. Liaudet-Coopman, E.D.E. & Wellstein, A. Regulation of gene expression of a binding protein for fibroblast growth factor by retinoic acid. J. Biol. Chem. 271, 21303-21308 (1996).
13. Kurtz, A., Darwiche, N., Harris, V., Wang, H.L. & Wellstein, A. Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene 14, 2671-2681 (1997).
14. Czubayko, F., Riegel, AT. & Wellstein, A. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. J. Biol. Chem. 269, 21358-21363 (1994).
15. Li, Y.S. et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250, 1690-1694 (1990).
16. Fang, W.J., Hartmann, N., Chow, D., Riegel, A.T. & Wellstein, A. Pleiotrophin stimulates fibroblasts, endothelial and epithelial cells, and is expressed in human cancer. J. Biol. Chem. 267, 25889-25897 (1992).
17. Liaudet-Coopman, E.D.E., Berchem, G.J. & Wellstein, A. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma. Clin. Cancer Res. 3, 179-184 (1997).
18. Horak, E.R. et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340, 1120-1124 (1992).
19. Kuan, S.F., Byrd, J.C., Basbaum, C.B. & Kim, Y.S. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res. 47, 5715-5724 (1987).
20. Chen, C.J., Banerjea, A.C., Harmison, G.G., Haglund, K. & Schubert, M. Multi-target-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication - potential effectiveness against most presently sequenced HIV-1 isolates. Nucleic Acids Res. 20, 4581-4589 (1992).